FC
CVS icon

Fulcrum Capital’s CVS Health CVS Stock Holding History

Fulcrum Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
3,285
-552
-14% -$49.3K 0.07% 80
2026
Q1 		$276K Sell
3,837
-955
-20% -$73.6K 0.06% 87
2025
Q4 		$380K Buy
+4,792
New +$378K 0.08% 73
2024
Q2 		– Sell
-4,000
Closed -$319K – 111
2024
Q1 		$319K Hold
4,000
– – 0.08% 86
2023
Q4 		$316K Hold
4,000
– – 0.08% 84
2023
Q3 		$279K Sell
4,000
-400
-9% -$28.3K 0.08% 86
2023
Q2 		$304K Hold
4,400
– – 0.08% 89
2023
Q1 		$327K Buy
4,400
+400
+10% +$33.5K 0.09% 85
2022
Q4 		$373K Hold
4,000
– – 0.11% 77
2022
Q3 		$381K Hold
4,000
– – 0.11% 66
2022
Q2 		$371K Hold
4,000
– – 0.12% 60
2022
Q1 		$405K Hold
4,000
– – 0.11% 59
2021
Q4 		$413K Hold
4,000
– – 0.09% 67
2021
Q3 		$339K Hold
4,000
– – 0.08% 71
2021
Q2 		$334K Sell
4,000
-49
-1% -$4.01K 0.08% 63
2021
Q1 		$305K Buy
4,049
+49
+1% +$3.57K 0.09% 65
2020
Q4 		$273K Hold
4,000
– – 0.08% 67
2020
Q3 		$234K Hold
4,000
– – 0.08% 56
2020
Q2 		$260K Buy
+4,000
New +$252K 0.1% 61
2020
Q1 		– Sell
-3,500
Closed -$260K – 66
2019
Q4 		$260K Hold
3,500
– – 0.08% 66
2019
Q3 		$221K Sell
3,500
-1,600
-31% -$94.8K 0.08% 68
2019
Q2 		$278K Sell
5,100
-80,095
-94% -$4.31M 0.1% 53
2019
Q1 		$4.59M Buy
85,195
+8,889
+12% +$549K 1.74% 27
2018
Q4 		$5M Buy
76,306
+12,005
+19% +$896K 2.25% 17
2018
Q3 		$5.06M Buy
64,301
+6,188
+11% +$442K 1.97% 19
2018
Q2 		$3.74M Buy
58,113
+4,141
+8% +$273K 1.79% 25
2018
Q1 		$3.36M Buy
53,972
+2,059
+4% +$148K 1.09% 33
2017
Q4 		$3.76M Buy
+51,913
New +$3.77M 1.22% 30

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fulcrum Capital's CVS Position: Q2 2026 in Review

Fulcrum Capital reduced its CVS Health (CVS) stake by 14% in Q2 2026, selling an estimated $49.3K and leaving 3,285 shares worth $340K. The position accounts for 0.07% of the portfolio, ranked #80.

Fulcrum Capital first reported a position in CVS in Q4 2017 and has held it in 28 quarters since. The position peaked at $5.06M in Q3 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fulcrum Capital held 3,285 shares of CVS Health worth $340K as of Q2 2026.
  • Fulcrum Capital sold 552 CVS Health shares in Q2 2026, an estimated $49.3K.
  • CVS Health made up 0.07% of Fulcrum Capital's portfolio in Q2 2026, its #80 holding.
  • Fulcrum Capital first reported a position in CVS Health in Q4 2017 and has held it in 28 quarters since.
  • Fulcrum Capital's CVS Health position peaked at $5.06M in Q3 2018.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.